Full-Time

Associate Director

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops novel therapies for central nervous system conditions.

Biotechnology

$150,000 - $190,000

Bonus, Equity

Senior

New York, NY, USA

Required Skills
Sales
Operations Research
Data Analysis
Requirements
  • Bachelor's degree preferably Engineering, Math, Physics, Statistics & Operations Research
  • 7+ years pharmaceutical or biotechnology experience in Commercial Analytics/Forecasting or Sales Analytics roles
  • Advanced degree, including MBA, or Masters/PhD in a quantitative field such as Engineering, Math, Physics, Statistics & Operations Research preferred
  • Previous product launch experience
  • Ability to work on site Monday, Tuesday & Thursday. We are unable to consider candidates who are looking for fully remote roles.
Responsibilities
  • Generate analytics-based insights by leveraging various pharmaceutical data sources
  • Collaborate closely with other commercial analytics and insights team members
  • Update and maintain brand forecast models
  • Create short term and long term forecasts and effectively communicate them to various stakeholders
  • Easily translate commercial analytics results to help deepen our understanding of market opportunities and customer behaviors
  • Turn unstructured business issues/requests into appropriate analytical action plans and projects
  • Provide accurate and in-depth analyses to commercial leadership teams
  • Support initiatives by leveraging expertise in drawing insights from large data sets
  • Manage multiple complex pieces of data analysis and translating that analysis into actionable commercial insights
  • Identify, evaluate, and manage relationships with best-in-class analytics vendors

Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics, Inc. stands out as a leader in the biopharmaceutical industry due to its dedicated focus on developing novel therapies for central nervous system conditions, an area with limited treatment options. The company's commitment to creating products that significantly improve patient lives demonstrates a strong, patient-centered culture. Its unique approach to treating CNS conditions through the development of therapeutic options with novel mechanisms of action showcases its technical innovation and competitive edge in the industry.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

22%

1 year growth

48%

2 year growth

399%